Phase II Trial of Sorafenib in Advanced Thyroid Cancer von GUPTA-ABRAMSON, Vandana, TROXEL, Andrea B, BROSE, Marcia S, NELLORE, Anoma, PUTTASWAMY, Kanchan, REDLINGER, Maryann, RANSONE, Kathy, MANDEL, Susan J, FLAHERTY, Keith T, LOEVNER, Laurie A, O'DWYER, Peter J

Volltext

A Phase I Trial of the Oral, Multikinase Inhibitor Sorafenib in Combination with Carboplatin and Paclitaxel von Flaherty, Keith T, Schiller, Joan, Schuchter, Lynn M, Liu, Glenn, Tuveson, David A, Redlinger, Maryann, Lathia, Chetan, Xia, Chenghua, Petrenciuc, Oana, Hingorani, Sunil R, Jacobetz, Michael A, Van Belle, Patricia A, Elder, David, Brose, Marcia S, Weber, Barbara L, Albertini, Mark R, O'Dwyer, Peter J

Volltext

Autophagy Inhibition to Augment mTOR Inhibition: a Phase I/II Trial of Everolimus and Hydroxychloroquine in Patients with Previously Treated Renal Cell Carcinoma von Haas, Naomi B, Appleman, Leonard J, Stein, Mark, Redlinger, Maryann, Wilks, Melissa, Xu, Xiaowei, Onorati, Angelique, Kalavacharla, Anusha, Kim, Taehyong, Zhen, Chao Jie, Kadri, Sabah, Segal, Jeremy P, Gimotty, Phyllis A, Davis, Lisa E, Amaravadi, Ravi K

Volltext

Combined MTOR and autophagy inhibition: Phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma von Rangwala, Reshma, Chang, Yunyoung C, Hu, Janice, Algazy, Kenneth M, Evans, Tracey L, Fecher, Leslie A, Schuchter, Lynn M, Torigian, Drew A, Panosian, Jeffrey T, Troxel, Andrea B, Tan, Kay-See, Heitjan, Daniel F, DeMichele, Angela M, Vaughn, David J, Redlinger, Maryann, Alavi, Abass, Kaiser, Jonathon, Pontiggia, Laura, Davis, Lisa E, O'Dwyer, Peter J, Amaravadi, Ravi K

Volltext

Radiomic profiles via machine learning to predict response, overall survival, and KRAS status in metastatic colorectal tumors treated with FOLFOX/bevacizumab/hydroxychloroquine von Rathore, Saima, O'Hara, Mark H., Karasic, Thomas Benjamin, Redlinger, Maryann, Rosen, Mark Alan, Davatzikos, Christos, O'Dwyer, Peter

Volltext

Phase I Clinical and Pharmacogenetic Trial of Irinotecan and Raltitrexed Administered Every 21 Days to Patients With Cancer von STEVENSON, James P, REDLINGER, Maryann, KLUIJTMANS, Leo A. J, WEIJING SUN, ALGAZY, Kenneth, GIANTONIO, Bruce, HALLER, Daniel G, HARDY, Christine, WHITEHEAD, Alexander S, O'DWYER, Peter J

Volltext

Phase I and Pharmacokinetic Trial of the Proapoptotic Sulindac Analog CP-461 in Patients with Advanced Cancer von Sun, Weijing, Stevenson, James P, Gallo, James M, Redlinger, Maryann, Haller, Daniel, Algazy, Kenneth, Giantonio, Bruce, Alila, Hector, O'Dwyer, Peter J

Volltext

Phase II trial of the autophagy inhibitor hydroxychloroquine with FOLFOX and bevacizumab in front line treatment of metastatic colorectal cancer von O'Hara, Mark H., Karasic, Thomas Benjamin, Vasilevskaya, Irina, Redlinger, Maryann, Loaiza-Bonilla, Arturo, Teitelbaum, Ursina R., Giantonio, Bruce J., Damjanov, Nevena, Reiss, Kim Anna, Rosen, Mark Alan, Heitjan, Daniel F, Troxel, Andrea B., Amaravadi, Ravi K., O'Dwyer, Peter J.

Volltext

Interaction of sorafenib and cytochrome P450 isoenzymes in patients with advanced melanoma: a phase I/II pharmacokinetic interaction study von Flaherty, Keith T., Lathia, Chetan, Frye, Reginald F., Schuchter, Lynn, Redlinger, Maryann, Rosen, Mark, O’Dwyer, Peter J.

Volltext

Phase II trial of autophagy inhibition using hydroxychloroquine (HCQ) with FOLFOX/bevacizumab in the first-line treatment of advanced colorectal cancer von Loaiza-Bonilla, Arturo, O'Hara, Mark H., Redlinger, Maryann, Damjanov, Nevena, Teitelbaum, Ursina R., Vasilevskaya, Irina, Rosen, Mark Alan, Heitjan, Daniel F, Amaravadi, Ravi K., O'Dwyer, Peter J.

Volltext

Phase 1 and pharmacodynamic trial of everolimus in combination with cetuximab in patients with advanced cancer von Ciunci, Christine A., Perini, Rodolfo F., Avadhani, Anjali N., Kang, Hyunseon C., Sun, Weijing, Redlinger, Maryann, Harlacker, Kathleen, Flaherty, Keith T., Giantonio, Bruce J., Rosen, Mark A., Divgi, Chaitanya R., Song, Hee Kwon, Englander, Sarah, Troxel, Andrea, Schnall, Mitchell, O'Dwyer, Peter J.

Volltext

Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors von Denlinger, Crystal S, Blanchard, Rebecca, Xu, Lu, Bernaards, Coen, Litwin, Samuel, Spittle, Cynthia, Berg, Daniel J, McLaughlin, Susan, Redlinger, Maryann, Dorr, Andrew, Hambleton, Julie, Holden, Scott, Kearns, Anne, Kenkare-Mitra, Sara, Lum, Bert, Meropol, Neal J, O'Dwyer, Peter J

Volltext

Abstract 4500: Combined mTOR inhibition and autophagy inhibition: Phase I trial of temsirolimus and hydroxchloroquine in patients with advanced solid tumors von Algazy, Kenneth M., Schuchter, Lynn M., Demichele, Angela M., David, Vaughn J., Torigian, Drew A., Chang, Claire Y., Redlinger, Maryann, Davis, Lisa E., O'Dwyer, Peter J., Amaravadi, Ravi K.

Volltext

Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors von DENLINGER, Crystal S, BLANCHARD, Rebecca, HAMBLETON, Julie, HOLDEN, Scott, KEARNS, Anne, KENKARE-MITRA, Sara, LUM, Bert, MEROPOL, Neal J, O'DWYER, Peter J, LU XU, BERNAARDS, Coen, LITWIN, Samuel, SPITTLE, Cynthia, BERG, Daniel J, MCLAUGHLIN, Susan, REDLINGER, Maryann, DORR, Andrew

Volltext

A phase I, dose escalation trial of ZD0473, a novel platinum analogue, in combination with gemcitabine von FLAHERTY, Keith T, STEVENSON, James P, REDLINGER, Maryann, ALGAZY, Kenneth M, GIANTONIO, Bruce, O'DWYER, Peter J

Volltext

Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy von FLAHERTY, Keith T, STEVENSON, James P, HAHN, Stephen M, REDLINGER, Maryann, O'DWYER, Peter J

Volltext

Irinotecan and UFT/leucovorin in patients with advanced cancers von Stevenson, J P, Redlinger, M, Sun, W, Haller, D, O'Dwyer, P J

Volltext

Combination Paclitaxel and Palbociclib: Results of a Phase I Trial in Advanced Breast Cancer von Clark, Amy S, McAndrew, Nicholas P, Troxel, Andrea, Feldman, Michael, Lal, Priti, Rosen, Mark, Burrell, Jessica, Redlinger, Colleen, Gallagher, Maryann, Bradbury, Angela R, Domchek, Susan M, Fox, Kevin R, O'Dwyer, Peter J, DeMichele, Angela M

Volltext

A phase I trial of palbociclib and paclitaxel in metastatic breast cancer von Clark, Amy Sanders, O'Dwyer, Peter J., Heitjan, Daniel, Lal, Priti, Feldman, Michael D, Gallagher, Maryann, Redlinger, Colleen, Colameco, Christopher, Lewis, David, Zafman, Kelly, Langer, Melissa, Rosen, Mark Alan, Gogineni, Keerthi, Bradbury, Angela R., Domchek, Susan M., Fox, Kevin R., DeMichele, Angela

Volltext